Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) had its price target raised by investment analysts at Needham & Company LLC from $36.00 to $54.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 15.29% […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) had its price target raised by investment analysts at Needham & Company LLC from $36.00 to $54.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 15.29% […]
